HTA Details
Flash Glucose Monitoring System for People with Type 1 or Type 2 Diabetes
- Publication date
-
2019-December-12
- Status
- Final
- Topic Area
- Diabetes and Other Endocrinal, Nutritional and Metabolic
- Recommendation
-
Final Recommendation
Ontario Health, based on the guidance of the Ontario Health Technology Advisory Committee, recommends publicly funding flash glucose monitoring systems for:
- People with type 1 diabetes who experience recurrent hypoglycemia despite frequent self-monitoring of blood glucose and efforts to optimize insulin management
- People with type 2 diabetes requiring intensive insulin therapy (multiple daily injections of insulin or continuous subcutaneous insulin infusion) who experience recurrent hypoglycemia despite frequent self-monitoring of blood glucose and efforts to optimize insulin management
- Ministry Response
-
The Ministry of Health has accepted this recommendation.
-
People with diabetes manage their condition by checking the amount of glucose (a type of sugar) in their blood several times a day. The standard way to do this is to prick a finger to obtain a drop of blood and getting a reading of glucose levels using a blood glucose meter. This is called self-monitoring of blood glucose.
Flash glucose monitoring is a new method of measuring blood glucose levels. It uses a small sensor inserted under the skin of a person’s upper arm and a separate touchscreen reader device.
Ontario Health, in collaboration with the Canadian Agency for Drugs and Technologies in Health (CADTH), looked at how safe and effective flash glucose monitoring is for people with type 1 or type 2 diabetes and the budget impact of publicly funding flash glucose monitoring. We also talked with adults with diabetes and parents of children with diabetes to learn about their experiences, preferences, and values.
Last Updated: February 24, 2026
